List of works - lars nilsson

An improved CPRG colorimetric ligand-receptor signal transduction assay based on beta-galactosidase activity in mammalian BWZ-reporter cells

scientific article published in December 2017

Appearance of Cxcl10-expressing cell clusters is common for traumatic brain injury and neurodegenerative disorders

scientific article

Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice.

scientific article published on 12 October 2013

CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults

scientific article published on 08 December 2019

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease

scientific article published on 27 April 2016

Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation.

scientific article published in October 2004

Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.

scientific article published on August 2007

Effects of experimental Mycoplasma pulmonis infection on sensory neuropeptides and airway mucosa in the rat ⬇️

scientific article published on 01 October 1997

Elevated mRNA-levels of gonadotropin-releasing hormone and its receptor in plaque-bearing Alzheimer's disease transgenic mice

scientific article

Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice.

scientific article

Glial activation and inflammation along the Alzheimer's disease continuum

scientific article published on 21 February 2019

Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-β in murine brain ⬇️

scientific article published on June 13, 2012

Identification of amyloid beta mid-domain fragments in human cerebrospinal fluid

scientific article

Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.

scientific article published on 9 October 2015

Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging

scientific article

Overexpression of heparanase lowers the amyloid burden in amyloid-β precursor protein transgenic mice

scientific article published on 29 December 2014

Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brain ⬇️

scientific article published on October 1, 1991

Sensitive detection of Aβ protofibrils by proximity ligation--relevance for Alzheimer's disease

scientific article

Somatostatin receptors and the modulation of adenylyl cyclase activity in Alzheimer's disease ⬇️

scientific article published on August 1, 1991

Specific uptake of an amyloid-β protofibril-binding antibody-tracer in AβPP transgenic mouse brain.

scientific article published in January 2013

Systemic LPS-induced Aβ-solubilization and clearance in AβPP-transgenic mice is diminished by heparanase overexpression

scientific article published on 14 March 2019

The Alzheimer's disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway

scientific article

The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Aβ

scientific article

The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ.

scientific article published on 26 November 2011

The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide ⬇️

scientific article published on April 14, 2011

The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation ⬇️

scientific article published on November 1, 2001

Transient OGG1, APE1, PARP1 and Polβ expression in an Alzheimer's disease mouse model

scientific article published on 11 October 2013

Translating research on brain aging into public health: a new type of immunotherapy for Alzheimer's disease ⬇️

scientific article published on December 1, 2010

Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences.

scientific article published in March 1999

USE OF FUSED CIRCULATIONS TO INVESTIGATE THE ROLE OF APOLIPOPROTEIN E AS AMYLOID CATALYST AND PERIPHERAL SINK IN ALZHEIMER'S DISEASE ⬇️

scientific article published on February 1, 2012

List of works by lars nilsson

An improved CPRG colorimetric ligand-receptor signal transduction assay based on beta-galactosidase activity in mammalian BWZ-reporter cells

Appearance of Cxcl10-expressing cell clusters is common for traumatic brain injury and neurodegenerative disorders

Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice.

CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease

Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation.

Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.

Effects of experimental Mycoplasma pulmonis infection on sensory neuropeptides and airway mucosa in the rat ⬇️

Elevated mRNA-levels of gonadotropin-releasing hormone and its receptor in plaque-bearing Alzheimer's disease transgenic mice

Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice.

Glial activation and inflammation along the Alzheimer's disease continuum

Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-β in murine brain ⬇️

Identification of amyloid beta mid-domain fragments in human cerebrospinal fluid

Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.

Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging

Overexpression of heparanase lowers the amyloid burden in amyloid-β precursor protein transgenic mice

Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brain ⬇️

Sensitive detection of Aβ protofibrils by proximity ligation--relevance for Alzheimer's disease

Somatostatin receptors and the modulation of adenylyl cyclase activity in Alzheimer's disease ⬇️

Specific uptake of an amyloid-β protofibril-binding antibody-tracer in AβPP transgenic mouse brain.

Systemic LPS-induced Aβ-solubilization and clearance in AβPP-transgenic mice is diminished by heparanase overexpression

The Alzheimer's disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway

The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Aβ

The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ.

The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide ⬇️

The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation ⬇️

Transient OGG1, APE1, PARP1 and Polβ expression in an Alzheimer's disease mouse model

Translating research on brain aging into public health: a new type of immunotherapy for Alzheimer's disease ⬇️

Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences.

USE OF FUSED CIRCULATIONS TO INVESTIGATE THE ROLE OF APOLIPOPROTEIN E AS AMYLOID CATALYST AND PERIPHERAL SINK IN ALZHEIMER'S DISEASE ⬇️